Quest Diagnostics
From Wikipedia, the free encyclopedia
Quest Diagnostics Incorporated (
NYSE:
DGX) is the world's leading provider of diagnostic testing, information and services. A
United States based corporation that provides
clinical laboratory services, the company has operations in the United States,
United Kingdom,
Mexico and through its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd, a laboratory in
India[1] in addition to service locations located in
Brazil. Quest Diagnostics also has collaborative agreements internationally with various hospitals and clinics.
[2] Quest Diagnostics also has operations in the US Territory of
Puerto Rico.
[3]
Quest Diagnostics is a member of the
Fortune 500 and the
S&P 500. The company's corporate headquarters were previously located in
Teterboro,
New Jersey where the largest business unit is located. Currently, the corporate headquarters are located in
Madison,
New Jersey[4] having moved there in October 2007 from
Lyndhurst, New Jersey.
[edit] History
- 1967: Founded by Paul A. Brown, MD as Metropolitan Pathology Laboratory, Inc., in New York.
- 1969: Name Changed to MetPath, Inc., in Teaneck, New Jersey.
- 1982: MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories.
- 1997: Quest Diagnostics becomes an independent company as a spin-off from Corning.
- 1997: Acquires clinical laboratory division of Branford, CT-based Diagnostic Medical Laboratory, Inc. (DML)[5].
- 1999: Acquires SmithKline Beecham Clinical Laboratories; GlaxoSmithKline still holds a large portion of Quest Diagnostics stock. The SmithKline Beecham acquisition includes a joint venture ownership with CompuNet Clinical Laboratory
- 2000: Launch of Six Sigma program leading the charge to raise the quality of healthcare delivery in the United States.[6]
- 2001: Completes acquisition of Ohio-based MedPlus, Inc. (NASDAQ: MEDP), a healthcare technology company.
- 2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc. (AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.
- 2003: Completes acquisition of California-based Unilab Corporation (NASDAQ: ULAB) in a transaction valued at approximately $800 million .
- 2005: Completes acquisition of Kansas-based LabOne, Inc. (NASDAQ: LABS) for approximately $934 million.
- 2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.
- 2007: Quest Diagnostics celebrates its 10th year after being spun off from Corning.
- 2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company.
- 2007: Acquires AmeriPath (and subsidiary Specialty Laboratories) from Welsh, Carson, Anderson & Stowe, becoming the leading provider of cancer diagnostic testing services.
[edit] Key Facts
- The nation's leading provider of diagnostic testing, information and services.
- Processed more than 151 million test requisitions in 2006.
- Approximately 43,500 full time employees.
- More than 33 regional laboratories in key U.S. markets, plus the UK and Mexico.
- Approximately 2,000 patient service Mothers
- Revenues of approximately $6.7 billion in 2007.
- Leadership in gene-based and esoteric testing.
- Leadership in workplace drug testing.
- Leadership in risk assessment services for life insurers.
[edit] See also
[edit] External links
[edit] References